Author

Abdul-Daaim Mohammed-Murtala

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis.

3-month DAPT followed by monotherapy significantly reduces bleeding without increasing ischemic events and crosses the futility boundary for MACCE and the benefit boundary for CRB, indicating conclusive evidence for bleeding reduction and futility for ischemic benefit.

C. Chinnatambi, Abdul Rahaman Ottun, Louise Sakowski et al. · Cardiovascular Revasculariza... · 0 citations

Aug 2026

Long-Term Outcomes of LAAO Versus DOACs in Nonvalvular Atrial Fibrillation: A Meta-Analysis of Randomized Trials.

LAAO demonstrated efficacy comparable to DOAC therapy in reducing the risk of MACCE, NACE, and ischemic events, while significantly reducing the risk of non-procedure-related bleeding.

Chidubem Ezenna, Khalid Sawalha, Sammudeen Ibrahim et al. · Pacing and clinical electrop... · 0 citations